Fresenius Medical Care Stock Current Valuation
| FMS Stock | USD 24.26 0.36 1.46% |
Valuation analysis of Fresenius Medical Care helps investors to measure Fresenius Medical's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. Enterprise Value Over EBITDA is likely to gain to 9.24 in 2025, whereas Enterprise Value Multiple is likely to drop 6.71 in 2025. Fundamental drivers impacting Fresenius Medical's valuation include:
Overvalued
Today
Please note that Fresenius Medical's price fluctuation is very steady at this time. Calculation of the real value of Fresenius Medical Care is based on 3 months time horizon. Increasing Fresenius Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Fresenius stock is determined by what a typical buyer is willing to pay for full or partial control of Fresenius Medical Care. Since Fresenius Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Fresenius Stock. However, Fresenius Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 24.26 | Real 21.76 | Target 23.45 | Hype 24.29 | Naive 24.48 |
The intrinsic value of Fresenius Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Fresenius Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Fresenius Medical Care helps investors to forecast how Fresenius stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Fresenius Medical more accurately as focusing exclusively on Fresenius Medical's fundamentals will not take into account other important factors: Fresenius Medical Care Company Current Valuation Analysis
Fresenius Medical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Fresenius Medical Current Valuation | 24.87 B |
Most of Fresenius Medical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Fresenius Medical Care is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Fresenius Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Fresenius Medical is extremely important. It helps to project a fair market value of Fresenius Stock properly, considering its historical fundamentals such as Current Valuation. Since Fresenius Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Fresenius Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Fresenius Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Fresenius Current Valuation Historical Pattern
Today, most investors in Fresenius Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Fresenius Medical's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Fresenius Medical current valuation as a starting point in their analysis.
Fresenius Medical Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Fresenius Medical Care has a Current Valuation of 24.87 B. This is 73.17% higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is 49.62% lower than that of the firm.
Fresenius Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Fresenius Medical's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Fresenius Medical could also be used in its relative valuation, which is a method of valuing Fresenius Medical by comparing valuation metrics of similar companies.Fresenius Medical is currently under evaluation in current valuation category among its peers.
Fresenius Medical Current Valuation Drivers
We derive many important indicators used in calculating different scores of Fresenius Medical from analyzing Fresenius Medical's financial statements. These drivers represent accounts that assess Fresenius Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Fresenius Medical's important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 10.0B | 8.4B | 4.5B | 5.6B | 6.4B | 8.9B | |
| Enterprise Value | 21.3B | 20.2B | 16.4B | 16.3B | 16.2B | 13.9B |
Fresenius Medical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Fresenius Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Fresenius Medical's managers, analysts, and investors.Environmental | Governance | Social |
Fresenius Fundamentals
| Return On Equity | 0.0484 | ||||
| Return On Asset | 0.0285 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | 0.08 % | ||||
| Current Valuation | 24.87 B | ||||
| Shares Outstanding | 586.83 M | ||||
| Shares Owned By Institutions | 7.00 % | ||||
| Number Of Shares Shorted | 607.74 K | ||||
| Price To Earning | 6.53 X | ||||
| Price To Book | 0.91 X | ||||
| Price To Sales | 0.75 X | ||||
| Revenue | 19.34 B | ||||
| Gross Profit | 4.76 B | ||||
| EBITDA | 3.21 B | ||||
| Net Income | 740.87 M | ||||
| Cash And Equivalents | 362.77 M | ||||
| Cash Per Share | 1.75 X | ||||
| Total Debt | 10.98 B | ||||
| Debt To Equity | 0.88 % | ||||
| Current Ratio | 1.18 X | ||||
| Book Value Per Share | 49.68 X | ||||
| Cash Flow From Operations | 2.39 B | ||||
| Short Ratio | 2.56 X | ||||
| Earnings Per Share | 1.00 X | ||||
| Price To Earnings To Growth | 0.49 X | ||||
| Target Price | 26.71 | ||||
| Number Of Employees | 111.51 K | ||||
| Beta | 0.91 | ||||
| Market Capitalization | 14.53 B | ||||
| Total Asset | 33.57 B | ||||
| Retained Earnings | 11.27 B | ||||
| Working Capital | 2.26 B | ||||
| Current Asset | 6.98 B | ||||
| Current Liabilities | 4.19 B | ||||
| Annual Yield | 0.03 % | ||||
| Five Year Return | 1.29 % | ||||
| Net Asset | 33.57 B | ||||
| Last Dividend Paid | 1.44 |
About Fresenius Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Fresenius Medical Care's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Fresenius Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Fresenius Medical Care based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Fresenius Stock Analysis
When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.